Evaluation of the Fixed-dose Combination of Irbesartan/Atorvastatin in Type 2 Diabetic Patients Diagnosed With Hyperlipidemia and Hypertension
Clinical trial NCT02842359 · COMPLETED
Trial details
- NCT number
- NCT02842359
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-23
- Primary completion
- 2018-04-19
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.